Deborah J. Neff - Jun 1, 2022 Form 4 Insider Report for Cytek Biosciences, Inc. (CTKB)

Role
Director
Signature
/s/ Valerie Barnett, Attorney-in-Fact for Deborah J. Neff
Stock symbol
CTKB
Transactions as of
Jun 1, 2022
Transactions value $
$0
Form type
4
Date filed
6/3/2022, 05:26 PM
Next filing
Jun 16, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTKB Stock Option (right to buy) Award $0 +47K $0.00 47K Jun 1, 2022 Common Stock 47K $9.67 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/36th of the shares subject to the option vest monthly over three years from the vesting commencement date of June 1, 2022. The option becomes fully vested on June 1, 2025.